update on the roles of immune system-derived microRNAs in cardiovascular diseases
Abstract. Cardiovascular diseases (CVD) are a leading cause of human death worldwide. Over the past two decades, the emerging field of cardioimmunology has demo
Abstract. Cardiovascular diseases (CVD) are a leading cause of human death worldwide. Over the past two decades, the emerging field of cardioimmunology has demo
This Spot the Diagnosis article refers to ‘Answer: Surviving the storm: ventricular fibrillation in the left ventricle assist device era’, by G. Campos et
Hiroki Yamanobe, MD, Kensaku Nishihira, MD, PhD, Mitsuhiro Yano, MD, PhD, Yoshisato Shibata, MD, Yujiro Asada, MD, PhD; Fatal intramyocardial dissecting he
AbstractAims. To assess use and associations with outcomes of glucagon-like peptide-1 receptor agonists (GLP-1 RA) in a real-world population with heart fa
AbstractAim. Recently, deep-learning artificial intelligence (AI) models have been trained to detect cardiovascular conditions, including hypertrophic card
AbstractAims. Myocardial infarction and heart failure are major cardiovascular diseases that affect millions of people in the USA with morbidity and mortal
AbstractIntroduction. Direct current cardioversion (DCCV) is a commonly utilised rhythm control technique for atrial fibrillation (AF). Follow-up typically
AbstractBackground. The prognosis for atrial fibrillation (AF) patients is based on data that is decades old. Given evolving standards of clinical practice
AbstractAims. Data on Glycoprotein IIb/IIIa inhibitors (GPI) use in real world ACS patients following the introduction of potent P2Y12 inhibitors and newer
AbstractAims. In hypoxia, endothelial cells (ECs) proliferate, migrate, and form new vasculature in a process called angiogenesis. Recent studies have sugg
AbstractBackground. Atrial fibrillation (AF) is prevalent, undiagnosed in approximately one-third of cases, and is associated with severe complications. Gu